Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del / F508del-CFTR or F508del / G551D-CFTR

Tezacaftor (formerly VX-661) is an investigational small molecule that improves processing and trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in vitro, and improves CFTR function alone and in combination with ivacaftor. To evaluate the safety and efficacy of tezacaftor...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of respiratory and critical care medicine Vol. 197; no. 2; pp. 214 - 224
Main Authors:	Donaldson, Scott H., Pilewski, Joseph M., Griese, Matthias, Cooke, Jon, Viswanathan, Lakshmi, Tullis, Elizabeth, Davies, Jane C., Lekstrom-Himes, Julie A., Wang, Linda T.
Format:	Journal Article
Language:	English
Published:	United States American Thoracic Society 15.01.2018
Subjects:	Administration, Oral Adolescent Adult Aminophenols - administration & dosage Aminophenols - adverse effects Benzodioxoles - administration & dosage Benzodioxoles - adverse effects Chloride Cystic fibrosis Cystic Fibrosis - diagnosis Cystic Fibrosis - drug therapy Cystic Fibrosis - genetics Cystic Fibrosis Transmembrane Conductance Regulator - genetics Cysts Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Drug dosages Drug Therapy, Combination Female Humans Indoles - administration & dosage Indoles - adverse effects Kinases Male Maximum Tolerated Dose Molecular Targeted Therapy - methods Mutation Original Patients Pediatrics Prognosis Proteins Quinolones - administration & dosage Quinolones - adverse effects Respiratory Function Tests Risk Assessment Severity of Illness Index Treatment Outcome Young Adult United States > US forced expiratory volume sweat chloride CFTR modulator cystic fibrosis transmembrane conductance regulator corrector
ISSN:	1073-449X, 1535-4970, 1535-4970
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!